OKC industry leaders continue advances in bio-tech

Published: Tuesday, April 21, 2020 By: Marcus Elwell Source: The POINT!

Recent ground-breaking discoveries made by Oklahoma City-based researchers have continued to help the city grow into a major player in the bioscience and technology marketplace. Updated advances include:


The company continues to expand its business globally offering genetic solutions for human (parentage, ancestry) and animal (identification and tracking) applications. Work continues to develop with its forensic testing services for mass disaster investigation, blood and tissue matching, and pharmaceutical product tampering.


Clinical trials for their drug, HPN1010, an oral medication to treat acute noise-induced hearing loss, continues. Approximately 10% of Americans ages 20-69 have suffered permanent damage to their hearing from excessive noise exposure; the Department of Veterans Affairs spends $216 million annually to treat hearing loss issues that result from a military career.


The company’s clinical testing services helps individuals suspected of suffering from treatable autoimmune conditions that is present as a neurological disease. The company is contributing to shifting paradigms in the diagnosis and treatment of mental disorders.

This article originally appeared in the April 2020 edition of The Point.

Back to top